Stoke Therapeutics (STOK) Stock Surges on Potential Genetic Treatment Breakthrough
PremiumMarket NewsStoke Therapeutics (STOK) Stock Surges on Potential Genetic Treatment Breakthrough
2M ago
Stoke Therapeutics appoints Eric Olson Chief Business Officer.
Premium
The Fly
Stoke Therapeutics appoints Eric Olson Chief Business Officer.
2M ago
Stoke Therapeutics reports Q2  EPS (46c), consensus (56c)
Premium
The Fly
Stoke Therapeutics reports Q2 EPS (46c), consensus (56c)
3M ago
Stoke Therapeutics reports Q1 EPS (57c), consensus (61c)
PremiumThe FlyStoke Therapeutics reports Q1 EPS (57c), consensus (61c)
6M ago
Stoke Therapeutics CFO Stephen Tulipano to resign, Thomas Leggett to succeed
Premium
The Fly
Stoke Therapeutics CFO Stephen Tulipano to resign, Thomas Leggett to succeed
6M ago
Stoke Therapeutics appoints Jason Hoitt as Chief Commercial Officer
Premium
The Fly
Stoke Therapeutics appoints Jason Hoitt as Chief Commercial Officer
7M ago
Stoke Therapeutics announces $75M common stock offering
PremiumThe FlyStoke Therapeutics announces $75M common stock offering
8M ago
Stoke Therapeutics price target raised to $17 from $13 at Wedbush
Premium
The Fly
Stoke Therapeutics price target raised to $17 from $13 at Wedbush
8M ago
Stoke Therapeutics price target raised to $22 from $14 at Needham
Premium
The Fly
Stoke Therapeutics price target raised to $22 from $14 at Needham
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100